VeriPsych was recently featured in “Psychiatric Times”.
Blood Tests for Diagnosis of Schizophrenia and Depression? By Arline Kaplan | August 10, 2011, – Newly developed blood tests for schizophrenia and for depression designed to augment current diagnostic approaches have attracted increased attention at recent major scientific meetings.

Recently, VeriPsych was featured in Open Minds, an online journal and resource for Mental Health professionals. Access the article here.

VeriPsych Recognized at European Entrepreneur Awards in Zurich –  read more here

Effective Treatment, Timely Fashion.  Blood-based diagnostic test aids in confirming the diagnosis of recent onset schizophrenia.

Read the entire Article Here

Welcome National Alliance for Mental Illness Visitors — Please follow this link

Rules-Based Medicine aims for new medical frontier with test for schizophrenia
http://www.statesman.com/business/rules-based-medicine-aims-for-new-medical-frontier-1009205.html

Announcement coincides with Mental Illness Awareness Week, October 3 – 9, 2010

AUSTIN, Texas — October 6, 2010 /PRNewswire/ – Rules-Based Medicine, Inc. (RBM), today announced the widespread commercial availability of VeriPsych™ ( http://www.veripsych.com ), the first and only blood-based diagnostic test to aid in confirming the diagnosis of recent onset schizophrenia, a potentially devastating and costly mental illness that affects about 24 million people worldwide. VeriPsych is an innovative molecular diagnostic tool designed to complement the healthcare provider’s clinical impression.

Click here to see our full Multimedia press release.

VeriPsych, a diagnostic aid for the confirmation of a diagnosis of Schizophrenia is a proud sponsor of the Austin Chapter of the National Alliance for Mental Illness (NAMI) walk on October 2, 2010.

Read more here

To read an abstract or to access the entire paper — click here.